Editorial Comment from Dr Chapple to Long ‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
International Journal of Urology, EarlyView.
Source: International Journal of Urology - Category: Urology & Nephrology Authors: Christopher R Chapple B.Sc., M.D., F.R.C.S. (Urol), F.E.B.U. Source Type: research
More News: Japan Health | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology